Ikeda, Japan

Ryoji Sekiyama

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryoji Sekiyama. Retrieved from https://idiyas.com/inventor/ryoji-sekiyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryoji Sekiyama: Innovator in Antibacterial Agents

Introduction

Ryoji Sekiyama is a notable inventor based in Ikeda, Japan. He has made significant contributions to the field of antimicrobial agents, particularly in the prevention and treatment of bacterial infections. His innovative work has the potential to impact healthcare positively.

Latest Patents

Ryoji Sekiyama holds a patent for an antimicrobial agent that effectively combats bacteria from multiple genera, including Streptococcus, Moraxella, Haemophilus, and Klebsiella. The invention combines a penicillin antibiotic, specifically amoxicillin, with a cephem antibiotic, such as cefixime or cefdinir. This antimicrobial agent can be administered as a mixed preparation or as individual preparations for combined administration.

Career Highlights

Ryoji Sekiyama is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in developing innovative pharmaceutical solutions. His work in the field of antibiotics showcases his commitment to advancing medical science and improving patient outcomes.

Collaborations

Throughout his career, Ryoji Sekiyama has collaborated with esteemed colleagues, including Yoshimi Matsumoto and Shuichi Tawara. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ryoji Sekiyama's contributions to the development of antibacterial agents highlight his role as a significant inventor in the pharmaceutical industry. His innovative approach to combating bacterial infections demonstrates the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…